Studio City Logo_v3 (1).jpg
Studio City International Holdings Limited Announces Filing of Annual Report on Form 20-F for Fiscal Year 2021
31 mars 2022 07h05 HE | Studio City
MACAU, March 31, 2022 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City Logo_v3 (1).jpg
Studio City International Holdings Limited Announces Unaudited Fourth Quarter 2021 Earnings
01 mars 2022 08h05 HE | Studio City
MACAU, March 01, 2022 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City Logo_v3 (1).jpg
Studio City Company Announces Pricing of Senior Secured Notes Offering
09 févr. 2022 14h20 HE | Studio City
MACAU, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Studio City Company Limited (“Studio City Company”) today announces that it priced its international offering of senior secured notes due 2027. Studio City...
Bone Therapeutics et Link Health signent un accord non-contractuel pour les droits mondiaux d’ALLOB
29 nov. 2021 01h00 HE | Bone Therapeutics SA
INFORMATION REGLEMENTEE Link Health recevra les droits mondiaux pour le développement, la fabrication et la commercialisation d'ALLOB. Bone Therapeutics sera éligible dès la...
Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB
29 nov. 2021 01h00 HE | Bone Therapeutics SA
REGULATED INFORMATION Link Health to be granted global rights for development, manufacturing and commercialization of ALLOB Bone Therapeutics to receive R&D cost reimbursement,...
Studio City Logo_v3 (1).jpg
Studio City International Holdings Limited Announces Unaudited Third Quarter 2021 Earnings
09 nov. 2021 08h12 HE | Studio City
MACAU, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Bone Therapeutics signe un partenariat de recherche avec Implant Therapeutics pour garantir son accès à des Cellules Souches Pluripotentes induites (CSPi)
28 sept. 2021 01h00 HE | Bone Therapeutics SA
INFORMATION REGLEMENTEE Bone Therapeutics bénéficiera de l’expertise d’Implant Therapeutics et pourra accéder à des lignées cellulaires Souches Pluripotentes induites (SPi), incluant des...
Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)
28 sept. 2021 01h00 HE | Bone Therapeutics SA
REGULATED INFORMATION Bone Therapeutics will gain access to iPS cell lines, including hypoimmunogenic cell lines, differentiation protocols and expertise iPSC technology allows for the...
Bone Therapeutics nomme Lieve Creten en qualité de Directeur financier par intérim
21 sept. 2021 01h00 HE | Bone Therapeutics SA
INFORMATION REGLEMENTEE Gosselies, Belgique, le 21 septembre 2021, 7h00 CEST – BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le...
Bone Therapeutics appoints Lieve Creten as interim Chief Financial Officer
21 sept. 2021 01h00 HE | Bone Therapeutics SA
REGULATED INFORMATION Gosselies, Belgium, 21 September 2021, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in...